2022-2029 年全球股骨干骨折市场
市场调查报告书
商品编码
1140737

2022-2029 年全球股骨干骨折市场

Global Femur Shaft Fracture Market - 2022-2029

出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 约2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

交通事故增加推动市场增长

汽车和摩托车碰撞是股骨干骨折最常见的原因。开车时被车辆撞到也是常见的原因。这些交通事故导致高能碰撞和股骨骨折,从而推动市场增长。根据世界卫生组织的数据,到 2021 年,将有大约 130 万人死于道路交通事故。另有 20-5000 万人遭受非致命伤害,其中许多人因受伤而致残。此类病例的增加对股骨干骨折的治疗产生了很高的需求,并促进了市场增长。世界上大约 93% 的道路死亡事故发生在新兴国家,儘管世界上大约 60% 的汽车车队都在这些国家。道路交通伤害是 5-29 岁儿童和青少年死亡的主要原因。每年约有 130 万人死于交通事故。

此外,研究活动的增加以及使用髓内钉进行股骨干治疗的发展推动了预测期内的市场增长。此外,越来越多的老年人出现易骨折的骨骼虚弱,这可能导致股骨干骨折病例增加。

然而,股骨干骨折需要手术治疗,作为一种临时治疗方法,将金属针和螺钉植入骨内,严重时通常进行髓内钉。这些手术的高成本是製约市场增长的一个因素。

地理渗透

预计北美地区将主导全球股骨干骨折市场

该研究按地区分析了全球市场的股骨干骨折市场,包括北美、欧洲、亚太地区、南美、中东和非洲。

北美在 2021 年将主导全球股骨干骨折市场。预计美国在预测期内将代表北美的大幅增长。由于已建立的医疗保健基础设施和高人均医疗保健费用,预计美国的股骨干骨折将增加。

预计亚太地区在预测期内的价值也将出现显着增长。预计交通事故的增加将推动该地区的市场增长。预计亚太地区股骨干骨折市场在预测期内将出现快速增长。这是为了促进该地区的市场增长,因为该地区的老年人口增加,老年人的弱骨很容易骨折。此外,中国和印度人口规模的增加、骨科疾病的增加以及经济增长也有望推动亚太地区股骨干骨折市场的增长。

竞争格局。

为全球市场增长做出贡献的主要股骨干骨折参与者包括 Stryker、B. Braun Melsungen AG、Zimmer Biomet、Smith & Johnson、Orthopedic Implants、Orthofix Holdings、Right Medical Group NV、Advanced Ortheopathic Solutions、Eisam Ortobedi 和 Tivi Sihazra .领先公司正在为全球股骨干骨折市场的增长采用新产品发布和扩张战略。2022 年 9 月,Stryker 推出了新的 Gamma4 髋部骨折钉系统。这种新的 Gamma 系统为外科医生提供了 Stryker 的下一代髓内钉系统。该系统适用于治疗稳定性和不稳定性骨折、骨稳定和矫正头部、转子、转子下和股骨干的骨畸形。该系统具有不同的功能,例如可将刮削机率降低 66% 的精密销。2022 年 3 月,B.Brown 收购了透析浓缩液製备专家 Intermet Medicine & Technique。此次收购完善了 B.Braun Avitum 部门作为体外血液治疗(透析)系统供应商的广泛产品组合。2021 年 9 月,B.Braun Melsungen AG 完成了对 Sterinova Inc. 的收购。Sterinova 将继续作为 B.Braun 的子公司运营。此次收购是公司发展的有力支持者,并推动了 Smith+Nephew 机器人和 Real Intelligence 战略。

COVID-19 的影响。它对全球股骨干骨折市场产生负面影响。

在 COVID-19 爆发期间,股骨干骨折减少。与 2019 年股骨干骨折数据相比,股骨干骨折病例减少了 28.4%。医院已经註意到骨折病例和手术的减少。由于封锁,交通事故案件因股骨干骨折减少而减少。交通限制和学校、企业和工厂等许多商业活动的关闭限制了居民的活动,减少了股骨干骨折病例的数量。

全球股骨干骨折市场报告提供了大约 53 个市场数据表、40 个数字和 170 页的结构。

目录

第一章 调查方法和范围

  • 调查方法
  • 调查目的和范围

第二章市场定义和概述

第三章执行摘要

  • 按类型划分的市场细分
  • 最终用户的市场细分
  • 区域市场细分

第四章市场动态

  • 市场影响因素
    • 促进者
      • 交通事故数量增加
      • 激活研发
    • 抑製剂
      • 飙升的治疗费用
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 供应链分析
  • 价值链分析
  • PEST分析
  • 定价分析
  • 监管分析
  • 保险报销分析
  • 未满足的需求
  • 专利趋势

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 中的价格动态
  • 供需谱
  • 大流行期间与市场相关的政府努力
  • 製造商的战略举措
  • 概括

第 7 章 按类型

  • 1型骨折
  • 2型骨折

第 8 章最终用户

  • 医院
  • 专科诊所和骨科诊所

第9章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东/非洲

第 10 章 竞争格局

  • 竞争情景
  • 市场/份额分析
  • 併购分析

第十一章公司简介

  • Stryker
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务概览
  • B. Braun Melsungen AG.
  • Zimmer Biomet.
  • Smith+Nephew.
  • Johnson & Johnson.
  • Orthopaedic Implant Company.
  • ORTHOFIX HOLDINGS, INC
  • WRIGHT MEDICAL GROUP N.V.
  • ADVANCED ORTHOPAEDIC SOLUTIONS
  • Aysam Ortopedi & Tibbi Cihazlar(*LIST NOT EXHAUSTIVE)

第 12 章 重要注意事项

第 13 章 数据管理

简介目录
Product Code: DMMD3136

Market Overview

Femur Shaft Fracture Market was valued at USD YY million in 2021. It is forecasted to reach USD YY million by 2029, growing at a CAGR of YY % during the forecast period (2022-2029).

A femur shaft fracture is a break along the length of the leg bone. Based on the force that causes the split, femur breaks differ tremendously. Bone parts will line up properly (stable fracture) or be out of alignment (displaced fracture). The skin can be intact around the fracture (closed fracture), or the skin can be punctured by the bone (open fracture). Typically, a fracturing of the femoral shaft produces acute, intense pain. The wounded leg would not be able to place weight on it, and it will appear deformed, thinner and no longer straight than the other leg. The major factors propelling the Femur shaft fracture market growth are the rising incidents of high-energy collisions, mainly road accidents falling from high altitudes, gunshots and more. The increasing prevalence of these incidents causes femur shaft fractures driving the market growth.

Market Dynamics: Increasing incidences of road accidents drives the market growth

A motor vehicle or motorcycle crash is the most prominent cause of femoral shaft fracturing. Another common cause is being struck by a vehicle while driving. These road accidents result in high-energy collisions, which break the femur bone driving the market growth. According to World Health Organization, in 2021, approximately 1.3 million people will be cut short due to a road traffic crash. Around 20 to 50 million more peoples suffer non-fatal injuries, with many incurring a disability due to their injury. This increase in cases creates a higher demand for femur shaft fracture treatment driving the market growth. Around 93% of the world's road fatalities occur in developing countries, even though these countries have approximately 60% of the world's vehicles. Road traffic injuries are a major cause of death for children and young adults aged 5-29 years. Approximately 1.3 million people die each year from road traffic crashes.

Also, increasing research activities along with the evolution of the use of intramedullary nails for treating the femur shaft market accelerates the market growth during the forecast period. Moreover, the rising geriatric population can lead to increasing cases of femur shaft fracture as the older population experiences weakness in bones which can easily be fractured.

However, the femur shaft fractures require surgery to heal, which uses metal pins, and screws being placed into the bone as a temporary treatment, while intramedullary nailing is used for severe cases. The cost for these surgeries is higher, which restricts the market growth.

Market Segmentation: The type 2 fracture segment is projected to be the dominant segment in the market during the forecast period.

Based on the type, the femur shaft fracture market has been classified into type 1 fracture and type 2 fractures.

Type 2 fracture dominated the global market in 2019, whereas Type 1 Fracture is expected to present considerable growth in the near future. Type 2 is a large butterfly of less than 50% of the bony width with greater than 50% of cortex intact. The severe accident mostly leads to Type 2 fracture owing to the higher energy collision which propels the segmental growth in the forecast period.

Femur shaft fracture is segmented based on End User, which includes Hospitals, Specialty/Orthopedic Clinics. Hospitals segment held significant market share in forecast period.

Most of the accidental cases are brought directly into the hospitals for treatment, supporting the segment growth during the forecast period. Moreover, the Specialty/Orthopedic Clinics is expected to project a considerable CAGR during the forecast period.

Geographical Penetration: North America region is expected to dominate the global femur shaft fracture market

Based on geography, the study analyzes the Femur Shaft Fracture market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America is holding a dominant position in the global Femur shaft fracture market in 2021. The U.S. is expected to represent considerable growth in North America during the forecast period. In the U.S., the femur shaft fracture is expected to grow owing to the Well-established healthcare infrastructure and high healthcare expenditure per capita.

Moreover, Asia Pacific is expected to represent significant growth in terms of value during the forecast period. Increasing road accidents are expected to propel market growth across the region. The femur shaft fracture market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the increasing geriatric population in the region, as the weak bones of the older population can easily be fractured, driving the market growth in the region. Also, a large population base, an increase in the incidence of orthopedic diseases, and economic growth in China, and India, are expected to augment the growth of the Asia Pacific femur shaft fracture market.

Competitive Landscape:

The key femur shaft fracture players which are contributing to the growth of the global market include Stryker, B. Braun Melsungen AG., Zimmer Biomet., Smith+Nephew., Johnson & Johnson., Orthopaedic Implant Company, Orthofix Holdings, Inc, Wright Medical Group N.V., Advanced Orthopaedic Solutions, Aysam Ortopedi & Tibbi Cihazlar, among others. The major players are adopting new product launches and expansion strategies for global growth in the femur shaft fracture market. In September 2022, Stryker launched New Gamma4 Hip Fracture Nailing System. This new Gamma System provided surgeons with the next generation of Stryker's intramedullary nailing system. This system is indicated for the treatment of stable and unstable fractures as well as for the stabilization of bones and correction of bone deformities in the intracapsular, trochanteric, subtrochanteric and shaft regions of the femur. This system has different features like precision pin, which reduce the potential of skiving by 66%. In March 2022, B.Braun acquired Intermedt Medizin & Technik GmbH, a specialist in preparing dialysis concentrates. Through this acquisition, the company completed the extensive product portfolio of its B. Braun Avitum division as a systems provider for extracorporeal blood treatment (dialysis). In September 2021, B.Braun Melsungen AG completed the acquisition of Sterinova Inc. Furthermore, Sterinova continues to operate as a subsidiary of B.Braun. In January 2022, Smith+Nephew, the global medical technology business, acquired Engage Surgical, owner of the only cementless unicompartmental (partial) knee system commercially available in the U.S. This acquisition strongly supports companies for growth and drove Smith+Nephew Robotics and Real Intelligence strategy.

COVID-19 Impact: Negative impact on the global femur shaft fracture market.

During the outbreak of COVID-19, there was a decrease in fractures in the femur shaft fracture. Compared to the 2019 femur shaft fracture data, there was a decrease in femur shaft fracture cases by 28.4%. The hospitals noticed a reduction in fracture cases and surgeries. Due to the lockdown, road accident cases are decreased due to reduced femur shaft fracture. With traffic restrictions and the closure of many commercial activities, a school, companies and factories have surely limited the movement of the population owing to a reduction in femur shaft fracture cases.

The global femur shaft fracture market report would provide an access to approximately 53 market data tables, 40 figures and 170 pages

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by End User
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing incidences of Road Accidents
      • 4.1.1.2. Increasing Research and development activities
    • 4.1.2. Restraints:
      • 4.1.2.1. High Cost of Treatment
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
  • 7.3. Market Attractiveness Index, By Type Segment
    • 7.3.1. Type 1 Fracture*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Type 2 Fracture

8. By End User

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  • 8.3. Market Attractiveness Index, By End User Segment
    • 8.3.1. Hospitals*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Specialty/Orthopedic Clinics

9. By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. U.S.
      • 9.4.5.2. Canada
      • 9.4.5.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. Germany
      • 9.5.5.2. U.K.
      • 9.5.5.3. France
      • 9.5.5.4. Italy
      • 9.5.5.5. Spain
      • 9.5.5.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.5.1. Brazil
      • 9.6.5.2. Argentina
      • 9.6.5.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.5.1. China
      • 9.7.5.2. India
      • 9.7.5.3. Japan
      • 9.7.5.4. Australia
      • 9.7.5.5. Rest of Asia Pacific
  • 9.8. Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Stryker*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. B. Braun Melsungen AG.
  • 11.3. Zimmer Biomet.
  • 11.4. Smith+Nephew.
  • 11.5. Johnson & Johnson.
  • 11.6. Orthopaedic Implant Company.
  • 11.7. ORTHOFIX HOLDINGS, INC
  • 11.8. WRIGHT MEDICAL GROUP N.V.
  • 11.9. ADVANCED ORTHOPAEDIC SOLUTIONS
  • 11.10. Aysam Ortopedi & Tibbi Cihazlar (*LIST NOT EXHAUSTIVE)

12. Premium Insights

13. DataM Intelligence Analysis

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us